EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV)

Clinical trials for EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV) explained in plain language.

Never miss a new study

Get alerted when new EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV) trials appear

Sign up with your email to follow new studies for EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can an mRNA vaccine stop a rare ebola strain?

⭐️ VACCINE ⭐️ Recruiting now

This early-stage trial is testing an experimental mRNA vaccine called mRNA-1469 to see if it is safe and can trigger an immune response against Ebola-Bundibugyo virus disease. Healthy adults aged 18 to 65 will receive either the vaccine or a placebo. The study focuses on safety a…

Matched conditions: EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV)

Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Aug 13, 2026 00:00 UTC

EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV)

Get alerted when new EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV) trials appear

Can an mRNA vaccine stop a rare ebola strain?